Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Biology / Biochemistry News

UCSD Researcher Receives 2009 Vanderbilt Prize

Main Category: Biology / Biochemistry
Also Included In: Cancer / Oncology
Article Date: 19 Oct 2009 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Susan Taylor, Ph.D., whose research has advanced understanding of how proteins are regulated in the body, has been awarded the 2009 Vanderbilt Prize in Biomedical Science.

The prize, established by the Vanderbilt University School of Medicine in 2006, honors women who have made significant advances in the biological and biomedical sciences and have contributed positively to the mentorship of other women in science.

The prize will be presented to Taylor, a professor of Chemistry and Biochemistry and of Pharmacology at the University of California, San Diego (UCSD), on Feb. 18, 2010, when she is scheduled to give a Vanderbilt Discovery Lecture.

It includes a $25,000 award and a funded scholarship named for Taylor that will support a woman beginning her M.D./Ph.D. studies at Vanderbilt. Taylor also will serve as a mentor for the student.

"This is a very innovative national prize showing public evidence of the value Vanderbilt places on discovery research, mentoring and women scientists," said Susan Wente, Ph.D., senior associate dean for Biomedical Sciences at VUSM.

In 1991, Taylor and her colleagues at UCSD solved the crystal structure of the first protein kinase -- protein kinase A or PKA. Protein kinases are enzymes that, by attaching phosphate groups to other proteins, can turn them "on" or "off" or otherwise affect their function.

PKA is found throughout the body, and helps regulate memory, development, cell growth and cell death. Defects in PKA are associated with immune disorders, heart disease and cancer. The anti-cancer drugs Gleevec and Iressa work by blocking kinase action.

Taylor has continued to advance understanding of how these crucial molecules work.

A member of the National Academy of Sciences, the Institute of Medicine and the Howard Hughes Medical Institute, she is also a past president of the American Society for Biochemistry and Molecular Biology, and has served on boards of counselors for the National Institutes of Health.

Source:
Bill Snyder
Vanderbilt University Medical Center

View drug information on Gleevec; Iressa.





Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
What Is Nutrition? Why Is Nutrition Important?
16 Aug 2009
Nutrition, nourishment, or aliment, is the supply of materials - food - required by organisms and cells to stay alive. In science and human medicine, nutrition is the science or practice of consuming and utilizing foods...


Coping with the Holiday Blues
Coping with the Holiday Blues

For many people, the holidays are a time of stress and sadness. Psychologist Dr. Carol Goldberg explores why and offers tips on how to avoid the holiday blues.

more videos are available in our health videos section.